by GlobeNewsWire | Aug 16, 2016 | Globe Newswire
WALTHAM, Mass., Aug. 16, 2016 (GLOBE NEWSWIRE) — Interleukin Genetics, Inc. (OTCQB:ILIU) today announced financial results for its fiscal second quarter of 2016, ended June 30, 2016, and provided a corporate update. “The second quarter was significant for...
by GlobeNewsWire | May 16, 2016 | Globe Newswire
Two Agreements Year to Date to Incorporate PerioPredict® into Employee Benefit Plans Conference call today at 8:30 AM Eastern Standard time WALTHAM, Mass., May 16, 2016 (GLOBE NEWSWIRE) — Interleukin Genetics, Inc. (OTCQB:ILIU) today announced financial and...
by GlobeNewsWire | Mar 30, 2016 | Globe Newswire
LEXINGTON, Mass., March 30, 2016 (GLOBE NEWSWIRE) — Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehydes, today announced its financial results for the year...
by GlobeNewsWire | Mar 24, 2016 | Globe Newswire
LEXINGTON, Mass., March 24, 2016 (GLOBE NEWSWIRE) — Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehydes, today announced that David J. Clark, M.D., Chief...
by GlobeNewsWire | Dec 16, 2015 | Globe Newswire
LEXINGTON, Mass., Dec. 16, 2015 (GLOBE NEWSWIRE) — Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehydes, today announced that the last patient has completed...